Research.Patient.info

Relapsed/refractory Acute Myeloid Leukemia or relapsed/refractory myelodysplastic syndromes research hub

1 indexed studies · 0 currently recruiting

authorisedHuman Pharmacology (Phase I)- First administration to humans
A Phase 1 Study of AUTX-703 in Participants with Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes
This study is looking into a new treatment called AUTX-703 for adults with particular types of blood cancer. This includes acute myeloid leukaemia (AML) or myelodysplastic syndromes (MDS) that have returned or haven't responded to previous treatments. It's an early-stage study to see if the treatment is safe.
France